FDA shuts down Pharmakon Labs of Florida
FDA Release
July 28, 2005



The U.S. Food and Drug Administration (FDA) today announced a permanent injunction shutting down operations at Pharmakon Labs of Florida. The company manufactured and distributed cough and cold liquids, tablets and caplets.

Following inspections by FDA and a trial in U.S. District Court, Judge Richard A. Lazzara found that drug products sold by Pharmakon Labs, Inc., its president Abelardo L. Acebo, and its secretary/treasurer Edward R. Jackson (the defendants) did not meet current good manufacturing practice (cGMP) standards and other legal requirements.

Judge Lazzara stated that he was "simply unwilling as a court of equity to place the health, safety, and welfare of the general public at risk in order to accommodate the economic well-being of Defendants." Thus, the defendants were ordered to stop manufacturing and distributing drugs until they become compliant with CGMP standards to the satisfaction of FDA and obtain marketing approvals.

"This action by Judge Lazzara sends a strong signal that FDA will take action against drugs that fail to meet quality standards," said FDA Commissioner Dr. Lester M. Crawford. "As the nation's top enforcer of manufacturing standards, the FDA will continue to ensure that drugs being sold in this country meet those crucial requirements."

The defendants have a long history of continued violations of the Federal Food, Drug, and Cosmetic Act. The government's initial complaint alleged numerous manufacturing violations documented in four inspections dating back to 2001. FDA later added charges related to Pharmakon's manufacture and distribution of unapproved new drugs, as part of the agency's longstanding policy to seek relief for all legal violations by a firm at the same time.

The government's request for a permanent injunction was based on the defendants' demonstrated unwillingness to comply with the law.

P05-47
July 27, 2005
Media Inquiries:
Suzanne Treviņo, 301-827-6242
Consumer Inquiries:
888-INFO-FDA





This is a U.S. Food and Drug Administration news release


Health News index | News index

News index | RSS | Add to MyYahoo!


Advertisements:


Organic Apparel from Patagonia | Insect-repelling clothing


MONGABAY.COM
Mongabay.com seeks to raise interest in and appreciation of wild lands and wildlife, while examining the impact of emerging trends in climate, technology, economics, and finance on conservation and development (more)

CONTENTS
Rainforests
Tropical Fish
News
Madagascar
Pictures
Kids' Site
Languages
TCS
T-shirts
Newsletter
About
Contact
Archives
Interns
Help


 
SUPPORT
Help support mongabay.com when you buy from Amazon.com

POPULAR PAGES
Rainforests
Rain forests
Amazon deforestation
Deforestation
Deforestation stats
Why rainforests matter
Saving rainforests
Deforestation stats
Rainforest canopy

News
Most popular
Worth saving?
Forest conservation
Earth Day
Poverty alleviation
Cell phones in Africa
Seniors helping Africa
Oil palm in rainforests
Extinction debate
Extinction crisis
Extinction debate
Palm Oil
Malaysian palm oil
Borneo
Orangutans in Borneo
Interviews



T-SHIRTS

  • Madagascar Wildlife
  • Dancing lemurs
  • Don't fall asleep the sloths will eat you
  • Sucking on this frog may make you insane


    CALENDARS

  • Mount Kenya
  • East Africa Safari Wildlife
  • Kenya's Turkana People
  • Peru
  • African Wildlife
  • Alaska
  • China
  • Madagascar Chameleons


    CANVAS BAGS

  • Hallucinogenic frog bag
  • Madagascar wildlife bag







  • Copyright mongabay 2007